UNITS PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic decline today following the unexpected cancellation of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending HIMS's stock price plummeting by over 10%. The reason for the collapse of the partnership remains unclear, but industry analysts speculate that it could be